

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.98748912 |
| 2 | negative regulation of fibrinolysis (GO:0051918) | 6.94191180 |
| 3 | plasma lipoprotein particle assembly (GO:0034377) | 6.46206096 |
| 4 | low-density lipoprotein particle remodeling (GO:0034374) | 6.07099024 |
| 5 | regulation of fibrinolysis (GO:0051917) | 5.94690486 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.78067972 |
| 7 | protein-lipid complex assembly (GO:0065005) | 5.76929469 |
| 8 | regulation of protein activation cascade (GO:2000257) | 5.63527000 |
| 9 | protein carboxylation (GO:0018214) | 5.62642620 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.62642620 |
| 11 | vocalization behavior (GO:0071625) | 5.51687945 |
| 12 | regulation of complement activation (GO:0030449) | 5.51218402 |
| 13 | cellular potassium ion homeostasis (GO:0030007) | 5.43141403 |
| 14 | regulation of apoptotic cell clearance (GO:2000425) | 5.34333435 |
| 15 | intestinal cholesterol absorption (GO:0030299) | 5.31483944 |
| 16 | synaptic vesicle exocytosis (GO:0016079) | 5.26966572 |
| 17 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.26870963 |
| 18 | synaptic vesicle maturation (GO:0016188) | 5.18425411 |
| 19 | locomotory exploration behavior (GO:0035641) | 5.01032268 |
| 20 | cholesterol efflux (GO:0033344) | 4.96420279 |
| 21 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.85778746 |
| 22 | protein-lipid complex remodeling (GO:0034368) | 4.82049387 |
| 23 | macromolecular complex remodeling (GO:0034367) | 4.82049387 |
| 24 | plasma lipoprotein particle remodeling (GO:0034369) | 4.82049387 |
| 25 | response to pheromone (GO:0019236) | 4.78970793 |
| 26 | * positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.78289196 |
| 27 | gamma-aminobutyric acid transport (GO:0015812) | 4.74316315 |
| 28 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.70310107 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 4.68533787 |
| 30 | plasma lipoprotein particle organization (GO:0071827) | 4.67488563 |
| 31 | blood coagulation, intrinsic pathway (GO:0007597) | 4.65390392 |
| 32 | glutamate secretion (GO:0014047) | 4.54400766 |
| 33 | neuron cell-cell adhesion (GO:0007158) | 4.53202740 |
| 34 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.50539834 |
| 35 | protein-lipid complex subunit organization (GO:0071825) | 4.40532677 |
| 36 | glutamate receptor signaling pathway (GO:0007215) | 4.40520287 |
| 37 | neurotransmitter secretion (GO:0007269) | 4.37075621 |
| 38 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 4.34436141 |
| 39 | * positive regulation of synapse maturation (GO:0090129) | 4.24055834 |
| 40 | cerebellar granule cell differentiation (GO:0021707) | 4.23223920 |
| 41 | * regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.20990918 |
| 42 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.19812812 |
| 43 | * protein localization to synapse (GO:0035418) | 4.18895614 |
| 44 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.13021702 |
| 45 | * layer formation in cerebral cortex (GO:0021819) | 4.12035655 |
| 46 | regulation of bile acid biosynthetic process (GO:0070857) | 4.08976228 |
| 47 | high-density lipoprotein particle remodeling (GO:0034375) | 4.07602813 |
| 48 | regulation of cholesterol homeostasis (GO:2000188) | 4.00952739 |
| 49 | regulation of plasminogen activation (GO:0010755) | 4.00040706 |
| 50 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.98747947 |
| 51 | reverse cholesterol transport (GO:0043691) | 3.97111957 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 3.96269096 |
| 53 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.95028603 |
| 54 | L-phenylalanine catabolic process (GO:0006559) | 3.95028603 |
| 55 | sodium ion export (GO:0071436) | 3.92566086 |
| 56 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.92363913 |
| 57 | exploration behavior (GO:0035640) | 3.89913850 |
| 58 | synaptic transmission, glutamatergic (GO:0035249) | 3.89632717 |
| 59 | negative regulation of protein activation cascade (GO:2000258) | 3.89382562 |
| 60 | lung epithelium development (GO:0060428) | 3.85360734 |
| 61 | regulation of synapse structural plasticity (GO:0051823) | 3.85299785 |
| 62 | neuron-neuron synaptic transmission (GO:0007270) | 3.84129439 |
| 63 | nucleobase catabolic process (GO:0046113) | 3.83145603 |
| 64 | regulation of synaptic vesicle transport (GO:1902803) | 3.81212856 |
| 65 | * regulation of glutamate receptor signaling pathway (GO:1900449) | 3.79340339 |
| 66 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.78685130 |
| 67 | nephron epithelium morphogenesis (GO:0072088) | 3.76048890 |
| 68 | nephron tubule morphogenesis (GO:0072078) | 3.76048890 |
| 69 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.75134782 |
| 70 | synaptic vesicle endocytosis (GO:0048488) | 3.75128892 |
| 71 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.73863108 |
| 72 | dendrite morphogenesis (GO:0048813) | 3.72877034 |
| 73 | potassium ion homeostasis (GO:0055075) | 3.71323300 |
| 74 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.69224566 |
| 75 | complement activation, alternative pathway (GO:0006957) | 3.67342871 |
| 76 | negative regulation of sodium ion transport (GO:0010766) | 3.65202917 |
| 77 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.64991763 |
| 78 | mating behavior (GO:0007617) | 3.63686368 |
| 79 | L-phenylalanine metabolic process (GO:0006558) | 3.63674397 |
| 80 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.63674397 |
| 81 | prepulse inhibition (GO:0060134) | 3.60225047 |
| 82 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.60212122 |
| 83 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.56404639 |
| 84 | intestinal absorption (GO:0050892) | 3.52833520 |
| 85 | synapse assembly (GO:0007416) | 3.52820422 |
| 86 | * neurotransmitter-gated ion channel clustering (GO:0072578) | 3.52680479 |
| 87 | neurotransmitter transport (GO:0006836) | 3.50916197 |
| 88 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.48618878 |
| 89 | neuron recognition (GO:0008038) | 3.46090919 |
| 90 | dendritic spine morphogenesis (GO:0060997) | 3.44104743 |
| 91 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.41482669 |
| 92 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.41363562 |
| 93 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.40068078 |
| 94 | diacylglycerol metabolic process (GO:0046339) | 3.35572805 |
| 95 | negative regulation of cholesterol transport (GO:0032375) | 3.34288045 |
| 96 | negative regulation of sterol transport (GO:0032372) | 3.34288045 |
| 97 | low-density lipoprotein particle clearance (GO:0034383) | 3.33655870 |
| 98 | proline transport (GO:0015824) | 3.32964847 |
| 99 | detection of light stimulus involved in visual perception (GO:0050908) | 3.31905106 |
| 100 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.31905106 |
| 101 | urinary tract smooth muscle contraction (GO:0014848) | 3.31347938 |
| 102 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.31314271 |
| 103 | cell migration in hindbrain (GO:0021535) | 3.30318262 |
| 104 | postsynaptic membrane organization (GO:0001941) | 3.29359046 |
| 105 | response to auditory stimulus (GO:0010996) | 3.27852731 |
| 106 | neuronal action potential propagation (GO:0019227) | 3.24502400 |
| 107 | transmission of nerve impulse (GO:0019226) | 3.23133899 |
| 108 | axon ensheathment in central nervous system (GO:0032291) | 3.22722517 |
| 109 | central nervous system myelination (GO:0022010) | 3.22722517 |
| 110 | cell communication by electrical coupling (GO:0010644) | 3.19819533 |
| 111 | * long-term memory (GO:0007616) | 3.19416351 |
| 112 | membrane hyperpolarization (GO:0060081) | 3.18262643 |
| 113 | regulation of neurotransmitter levels (GO:0001505) | 3.15534580 |
| 114 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.14726897 |
| 115 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.14508634 |
| 116 | C4-dicarboxylate transport (GO:0015740) | 3.13314186 |
| 117 | positive regulation of extracellular matrix organization (GO:1903055) | 3.13003404 |
| 118 | cell differentiation in hindbrain (GO:0021533) | 3.12894108 |
| 119 | * regulation of synapse maturation (GO:0090128) | 3.12760794 |
| 120 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.10048097 |
| 121 | regulation of neurotransmitter secretion (GO:0046928) | 3.06903023 |
| 122 | axon cargo transport (GO:0008088) | 3.06233656 |
| 123 | striatum development (GO:0021756) | 3.05937043 |
| 124 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.05826630 |
| 125 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.04079560 |
| 126 | retinal rod cell development (GO:0046548) | 3.02296919 |
| 127 | * regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.01963382 |
| 128 | positive regulation of blood coagulation (GO:0030194) | 3.01836568 |
| 129 | positive regulation of hemostasis (GO:1900048) | 3.01836568 |
| 130 | glutamate metabolic process (GO:0006536) | 3.01584483 |
| 131 | response to prostaglandin (GO:0034694) | 3.00269359 |
| 132 | lipoprotein metabolic process (GO:0042157) | 2.99890845 |
| 133 | behavioral response to cocaine (GO:0048148) | 2.99613797 |
| 134 | * positive regulation of membrane potential (GO:0045838) | 2.99350082 |
| 135 | axonal fasciculation (GO:0007413) | 2.98714108 |
| 136 | activation of protein kinase A activity (GO:0034199) | 2.98626936 |
| 137 | sterol transport (GO:0015918) | 2.98067143 |
| 138 | cholesterol transport (GO:0030301) | 2.98067143 |
| 139 | auditory behavior (GO:0031223) | 2.97366382 |
| 140 | neuromuscular process controlling balance (GO:0050885) | 2.96500168 |
| 141 | synapse organization (GO:0050808) | 2.96049460 |
| 142 | negative regulation of complement activation (GO:0045916) | 2.95896263 |
| 143 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.95132220 |
| 144 | cellular sodium ion homeostasis (GO:0006883) | 2.94877467 |
| 145 | cellular response to prostaglandin stimulus (GO:0071379) | 2.94548952 |
| 146 | * regulation of postsynaptic membrane potential (GO:0060078) | 2.93356638 |
| 147 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.91893615 |
| 148 | * positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.89970052 |
| 149 | long-term synaptic potentiation (GO:0060291) | 2.89085581 |
| 150 | membrane depolarization during action potential (GO:0086010) | 2.88839522 |
| 151 | long term synaptic depression (GO:0060292) | 2.88426276 |
| 152 | regulation of neurotransmitter transport (GO:0051588) | 2.86188319 |
| 153 | mitochondrion transport along microtubule (GO:0047497) | 2.85868451 |
| 154 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.85868451 |
| 155 | regulation of norepinephrine secretion (GO:0014061) | 2.85458216 |
| 156 | innervation (GO:0060384) | 2.85322414 |
| 157 | drinking behavior (GO:0042756) | 2.84610577 |
| 158 | regulation of humoral immune response (GO:0002920) | 2.84499814 |
| 159 | positive regulation of steroid metabolic process (GO:0045940) | 2.84372401 |
| 160 | * regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.84035235 |
| 161 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.83759925 |
| 162 | negative regulation of hemostasis (GO:1900047) | 2.82212923 |
| 163 | negative regulation of blood coagulation (GO:0030195) | 2.82212923 |
| 164 | phospholipid efflux (GO:0033700) | 2.82166381 |
| 165 | peptidyl-glutamic acid modification (GO:0018200) | 2.81888877 |
| 166 | regulation of vesicle fusion (GO:0031338) | 2.81632158 |
| 167 | behavioral defense response (GO:0002209) | 2.81032315 |
| 168 | behavioral fear response (GO:0001662) | 2.81032315 |
| 169 | adult walking behavior (GO:0007628) | 2.80686812 |
| 170 | renal tubule morphogenesis (GO:0061333) | 2.79227329 |
| 171 | cholesterol homeostasis (GO:0042632) | 2.77744774 |
| 172 | artery smooth muscle contraction (GO:0014824) | 2.76606192 |
| 173 | regulation of ARF protein signal transduction (GO:0032012) | 2.76325243 |
| 174 | protein activation cascade (GO:0072376) | 2.75650576 |
| 175 | proline metabolic process (GO:0006560) | 2.75218149 |
| 176 | sterol homeostasis (GO:0055092) | 2.75133952 |
| 177 | phosphate ion homeostasis (GO:0055062) | 2.75048327 |
| 178 | trivalent inorganic anion homeostasis (GO:0072506) | 2.75048327 |
| 179 | negative regulation of astrocyte differentiation (GO:0048712) | 2.74933392 |
| 180 | negative regulation of norepinephrine secretion (GO:0010700) | 2.73058658 |
| 181 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.72773011 |
| 182 | lipoprotein transport (GO:0042953) | 2.71155883 |
| 183 | fibrinolysis (GO:0042730) | 2.71033819 |
| 184 | positive regulation of coagulation (GO:0050820) | 2.70041284 |
| 185 | cellular anion homeostasis (GO:0030002) | 2.69255908 |
| 186 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.65801432 |
| 187 | acute-phase response (GO:0006953) | 2.65723293 |
| 188 | negative regulation of lipase activity (GO:0060192) | 2.62912614 |
| 189 | regulation of extracellular matrix organization (GO:1903053) | 2.56392077 |
| 190 | negative regulation of coagulation (GO:0050819) | 2.56112671 |
| 191 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.55055152 |
| 192 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.55055152 |
| 193 | positive regulation of hormone metabolic process (GO:0032352) | 2.54877317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 5.63785502 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.90734846 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.60631838 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.67116701 |
| 5 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 3.48575407 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.94356008 |
| 7 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.86956417 |
| 8 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.83071316 |
| 9 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.79132287 |
| 10 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.78098315 |
| 11 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.61023371 |
| 12 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.56855898 |
| 13 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.43998931 |
| 14 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.43538104 |
| 15 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.43538104 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.41885484 |
| 17 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.41237883 |
| 18 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.38123170 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35769004 |
| 20 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33782173 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.30725835 |
| 22 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.29603246 |
| 23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.29553323 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.28859449 |
| 25 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.25945720 |
| 26 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.23250022 |
| 27 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.17347029 |
| 28 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.13499890 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12860573 |
| 30 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.08806950 |
| 31 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 2.08642476 |
| 32 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.08408269 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07315686 |
| 34 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.04041272 |
| 35 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.03719663 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.94977382 |
| 37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88545000 |
| 38 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.85780508 |
| 39 | * AR_21572438_ChIP-Seq_LNCaP_Human | 1.85522454 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.84778716 |
| 41 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.83550086 |
| 42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.77828242 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.76956083 |
| 44 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.76616838 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71431930 |
| 46 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.70403534 |
| 47 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.62998548 |
| 48 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.58747341 |
| 49 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.54991035 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49894675 |
| 51 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.49325163 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47857606 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.43927487 |
| 54 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.43736662 |
| 55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.43555147 |
| 56 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.43391067 |
| 57 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.41143965 |
| 58 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.38135245 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34276535 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33575714 |
| 61 | AR_19668381_ChIP-Seq_PC3_Human | 1.33151077 |
| 62 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.32071429 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31744784 |
| 64 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29327288 |
| 65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.29188281 |
| 66 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29019774 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28613139 |
| 68 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27730245 |
| 69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27324860 |
| 70 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.27308494 |
| 71 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25667701 |
| 72 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23943645 |
| 73 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23875759 |
| 74 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.22909449 |
| 75 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22835941 |
| 76 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22059315 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.20259317 |
| 78 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20113406 |
| 79 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.19562037 |
| 80 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.19327768 |
| 81 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.18995786 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18089283 |
| 83 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16387331 |
| 84 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.16084966 |
| 85 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.15989038 |
| 86 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14702610 |
| 87 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14475219 |
| 88 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.14402949 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13877335 |
| 90 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.12773327 |
| 91 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11888788 |
| 92 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11084960 |
| 93 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.10607344 |
| 94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.10101952 |
| 95 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09846831 |
| 96 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.09727359 |
| 97 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09547964 |
| 98 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.08100628 |
| 99 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07619892 |
| 100 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07419848 |
| 101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07146708 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07062052 |
| 103 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05875754 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04951951 |
| 105 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03938023 |
| 106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03938023 |
| 107 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03293713 |
| 108 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03070803 |
| 109 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.02962845 |
| 110 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01701233 |
| 111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00678852 |
| 112 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00672865 |
| 113 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00576946 |
| 114 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.99604475 |
| 115 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.98328651 |
| 116 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97249547 |
| 117 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95972204 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95723747 |
| 119 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95585247 |
| 120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95267877 |
| 121 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94699189 |
| 122 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94689682 |
| 123 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92776818 |
| 124 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92422846 |
| 125 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.92187945 |
| 126 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.92121473 |
| 127 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91645882 |
| 128 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91220415 |
| 129 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.91109284 |
| 130 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91074719 |
| 131 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.91036111 |
| 132 | FUS_26573619_Chip-Seq_HEK293_Human | 0.90891861 |
| 133 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.90551781 |
| 134 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89722677 |
| 135 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89611326 |
| 136 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89163827 |
| 137 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89147318 |
| 138 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.88943197 |
| 139 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.88097910 |
| 140 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.86410625 |
| 141 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84308574 |
| 142 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.83158536 |
| 143 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.83158536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003122_maternal_imprinting | 6.70097678 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.18934651 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.82327379 |
| 4 | MP0003123_paternal_imprinting | 3.46022198 |
| 5 | MP0003195_calcinosis | 3.32243721 |
| 6 | MP0005423_abnormal_somatic_nervous | 3.23964005 |
| 7 | MP0003880_abnormal_central_pattern | 3.22182315 |
| 8 | MP0004270_analgesia | 3.22058052 |
| 9 | * MP0009046_muscle_twitch | 3.08654573 |
| 10 | MP0002063_abnormal_learning/memory/cond | 3.04831595 |
| 11 | MP0009745_abnormal_behavioral_response | 2.97939238 |
| 12 | MP0002064_seizures | 2.82588530 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.79066366 |
| 14 | MP0003121_genomic_imprinting | 2.74895184 |
| 15 | * MP0005551_abnormal_eye_electrophysiolog | 2.65392533 |
| 16 | MP0001984_abnormal_olfaction | 2.62937882 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.59917284 |
| 18 | MP0002822_catalepsy | 2.59528005 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.54825255 |
| 20 | MP0001486_abnormal_startle_reflex | 2.53196389 |
| 21 | MP0002272_abnormal_nervous_system | 2.44959140 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.34815880 |
| 23 | MP0002735_abnormal_chemical_nociception | 2.28292504 |
| 24 | * MP0002067_abnormal_sensory_capabilities | 2.15491710 |
| 25 | MP0000566_synostosis | 2.13169666 |
| 26 | * MP0002184_abnormal_innervation | 2.11161821 |
| 27 | MP0003329_amyloid_beta_deposits | 2.10007514 |
| 28 | MP0000778_abnormal_nervous_system | 2.01963579 |
| 29 | MP0002736_abnormal_nociception_after | 1.89376847 |
| 30 | MP0001915_intracranial_hemorrhage | 1.86976373 |
| 31 | MP0010368_abnormal_lymphatic_system | 1.84452727 |
| 32 | MP0002090_abnormal_vision | 1.83689697 |
| 33 | MP0001440_abnormal_grooming_behavior | 1.82830515 |
| 34 | MP0005409_darkened_coat_color | 1.80897836 |
| 35 | MP0002557_abnormal_social/conspecific_i | 1.78946754 |
| 36 | MP0003879_abnormal_hair_cell | 1.77842465 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.76238348 |
| 38 | * MP0008569_lethality_at_weaning | 1.75385384 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.75193101 |
| 40 | MP0004924_abnormal_behavior | 1.75193101 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.67347344 |
| 42 | MP0004885_abnormal_endolymph | 1.66862720 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.66502407 |
| 44 | MP0002733_abnormal_thermal_nociception | 1.65847114 |
| 45 | MP0000955_abnormal_spinal_cord | 1.65701066 |
| 46 | MP0001502_abnormal_circadian_rhythm | 1.65628182 |
| 47 | * MP0004811_abnormal_neuron_physiology | 1.65383164 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.62860805 |
| 49 | MP0001970_abnormal_pain_threshold | 1.62760160 |
| 50 | * MP0002882_abnormal_neuron_morphology | 1.56121441 |
| 51 | MP0006072_abnormal_retinal_apoptosis | 1.50044779 |
| 52 | MP0005360_urolithiasis | 1.43499174 |
| 53 | MP0005408_hypopigmentation | 1.43315978 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.43105728 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.41665624 |
| 56 | MP0000534_abnormal_ureter_morphology | 1.38843536 |
| 57 | MP0003941_abnormal_skin_development | 1.37086124 |
| 58 | MP0003567_abnormal_fetal_cardiomyocyte | 1.37048212 |
| 59 | * MP0002066_abnormal_motor_capabilities/c | 1.36653225 |
| 60 | MP0005499_abnormal_olfactory_system | 1.35815412 |
| 61 | MP0005394_taste/olfaction_phenotype | 1.35815412 |
| 62 | MP0006054_spinal_hemorrhage | 1.35443308 |
| 63 | * MP0002229_neurodegeneration | 1.32881343 |
| 64 | MP0004858_abnormal_nervous_system | 1.31805778 |
| 65 | MP0003942_abnormal_urinary_system | 1.30795485 |
| 66 | MP0006276_abnormal_autonomic_nervous | 1.30619344 |
| 67 | MP0000639_abnormal_adrenal_gland | 1.26297044 |
| 68 | MP0002139_abnormal_hepatobiliary_system | 1.26231200 |
| 69 | MP0003868_abnormal_feces_composition | 1.25084078 |
| 70 | MP0004142_abnormal_muscle_tone | 1.24916877 |
| 71 | MP0003633_abnormal_nervous_system | 1.23822078 |
| 72 | MP0005253_abnormal_eye_physiology | 1.22037409 |
| 73 | MP0000569_abnormal_digit_pigmentation | 1.21528260 |
| 74 | MP0005257_abnormal_intraocular_pressure | 1.20065255 |
| 75 | MP0004233_abnormal_muscle_weight | 1.19363798 |
| 76 | MP0005187_abnormal_penis_morphology | 1.17496491 |
| 77 | MP0004742_abnormal_vestibular_system | 1.16135256 |
| 78 | MP0003631_nervous_system_phenotype | 1.15772023 |
| 79 | * MP0002152_abnormal_brain_morphology | 1.15042040 |
| 80 | MP0004272_abnormal_basement_membrane | 1.15030880 |
| 81 | MP0005085_abnormal_gallbladder_physiolo | 1.14925627 |
| 82 | MP0003115_abnormal_respiratory_system | 1.14867169 |
| 83 | MP0003632_abnormal_nervous_system | 1.14120963 |
| 84 | MP0005646_abnormal_pituitary_gland | 1.13251522 |
| 85 | MP0000604_amyloidosis | 1.13174829 |
| 86 | MP0005365_abnormal_bile_salt | 1.07469744 |
| 87 | * MP0002752_abnormal_somatic_nervous | 1.04300926 |
| 88 | MP0003385_abnormal_body_wall | 1.04292785 |
| 89 | MP0009384_cardiac_valve_regurgitation | 1.03776895 |
| 90 | MP0008872_abnormal_physiological_respon | 1.03462002 |
| 91 | * MP0005195_abnormal_posterior_eye | 1.03244894 |
| 92 | MP0001188_hyperpigmentation | 1.02901299 |
| 93 | MP0003878_abnormal_ear_physiology | 1.00172841 |
| 94 | MP0005377_hearing/vestibular/ear_phenot | 1.00172841 |
| 95 | MP0004145_abnormal_muscle_electrophysio | 1.00110349 |
| 96 | MP0001177_atelectasis | 0.99838903 |
| 97 | MP0008875_abnormal_xenobiotic_pharmacok | 0.99635249 |
| 98 | MP0003634_abnormal_glial_cell | 0.99275271 |
| 99 | MP0002938_white_spotting | 0.97340666 |
| 100 | MP0002118_abnormal_lipid_homeostasis | 0.94021055 |
| 101 | MP0001529_abnormal_vocalization | 0.92500328 |
| 102 | MP0002638_abnormal_pupillary_reflex | 0.91481187 |
| 103 | MP0003011_delayed_dark_adaptation | 0.91426134 |
| 104 | MP0003787_abnormal_imprinting | 0.90979828 |
| 105 | MP0003315_abnormal_perineum_morphology | 0.90648595 |
| 106 | MP0002069_abnormal_eating/drinking_beha | 0.90268941 |
| 107 | MP0002233_abnormal_nose_morphology | 0.88431625 |
| 108 | MP0000751_myopathy | 0.87272310 |
| 109 | MP0004085_abnormal_heartbeat | 0.86648887 |
| 110 | MP0001286_abnormal_eye_development | 0.86255948 |
| 111 | MP0003690_abnormal_glial_cell | 0.85424122 |
| 112 | MP0002160_abnormal_reproductive_system | 0.84897209 |
| 113 | MP0010329_abnormal_lipoprotein_level | 0.83870219 |
| 114 | MP0000631_abnormal_neuroendocrine_gland | 0.83207538 |
| 115 | MP0002697_abnormal_eye_size | 0.82949794 |
| 116 | MP0001270_distended_abdomen | 0.82697812 |
| 117 | MP0004215_abnormal_myocardial_fiber | 0.81728385 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.80817971 |
| 119 | MP0006292_abnormal_olfactory_placode | 0.80707471 |
| 120 | MP0008789_abnormal_olfactory_epithelium | 0.79345925 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.77095774 |
| 122 | MP0000609_abnormal_liver_physiology | 0.76037368 |
| 123 | MP0001324_abnormal_eye_pigmentation | 0.75218138 |
| 124 | MP0000920_abnormal_myelination | 0.74573970 |
| 125 | MP0001293_anophthalmia | 0.73996639 |
| 126 | MP0005535_abnormal_body_temperature | 0.73709384 |
| 127 | MP0008874_decreased_physiological_sensi | 0.73371897 |
| 128 | MP0005084_abnormal_gallbladder_morpholo | 0.73274736 |
| 129 | MP0005058_abnormal_lysosome_morphology | 0.73208916 |
| 130 | MP0005220_abnormal_exocrine_pancreas | 0.73142191 |
| 131 | MP0003183_abnormal_peptide_metabolism | 0.72886873 |
| 132 | MP0003137_abnormal_impulse_conducting | 0.71938611 |
| 133 | MP0002092_abnormal_eye_morphology | 0.71132948 |
| 134 | MP0001963_abnormal_hearing_physiology | 0.71017303 |
| 135 | MP0005332_abnormal_amino_acid | 0.70340729 |
| 136 | MP0005645_abnormal_hypothalamus_physiol | 0.68956119 |
| 137 | MP0003119_abnormal_digestive_system | 0.68179416 |
| 138 | * MP0003861_abnormal_nervous_system | 0.67096700 |
| 139 | MP0003937_abnormal_limbs/digits/tail_de | 0.66672129 |
| 140 | MP0003890_abnormal_embryonic-extraembry | 0.64096011 |
| 141 | MP0002234_abnormal_pharynx_morphology | 0.61460038 |
| 142 | MP0002089_abnormal_postnatal_growth/wei | 0.58863605 |
| 143 | MP0003252_abnormal_bile_duct | 0.58636814 |
| 144 | * MP0010770_preweaning_lethality | 0.58416959 |
| 145 | * MP0002082_postnatal_lethality | 0.58416959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 6.29022052 |
| 2 | Focal motor seizures (HP:0011153) | 5.28576369 |
| 3 | Congenital stationary night blindness (HP:0007642) | 5.04026780 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 4.82374131 |
| 5 | Joint hemorrhage (HP:0005261) | 4.82008568 |
| 6 | Myokymia (HP:0002411) | 4.77500615 |
| 7 | Abnormality of the common coagulation pathway (HP:0010990) | 4.76579429 |
| 8 | Complement deficiency (HP:0004431) | 4.73559773 |
| 9 | Action tremor (HP:0002345) | 4.71472996 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 4.63234008 |
| 11 | Epileptic encephalopathy (HP:0200134) | 4.63025989 |
| 12 | Focal seizures (HP:0007359) | 4.42897650 |
| 13 | Absence seizures (HP:0002121) | 4.17947964 |
| 14 | Visual hallucinations (HP:0002367) | 4.15525929 |
| 15 | Small epiphyses (HP:0010585) | 3.91864198 |
| 16 | Febrile seizures (HP:0002373) | 3.87398135 |
| 17 | Acanthocytosis (HP:0001927) | 3.85425886 |
| 18 | Hypercholesterolemia (HP:0003124) | 3.73468634 |
| 19 | Mutism (HP:0002300) | 3.71643923 |
| 20 | Generalized tonic-clonic seizures (HP:0002069) | 3.65671605 |
| 21 | Broad alveolar ridges (HP:0000187) | 3.60952576 |
| 22 | Glomerulonephritis (HP:0000099) | 3.58361243 |
| 23 | Dialeptic seizures (HP:0011146) | 3.53756498 |
| 24 | Dysdiadochokinesis (HP:0002075) | 3.51511487 |
| 25 | Central scotoma (HP:0000603) | 3.49124115 |
| 26 | Gaze-evoked nystagmus (HP:0000640) | 3.48079554 |
| 27 | Spontaneous abortion (HP:0005268) | 3.43373739 |
| 28 | Hemorrhage of the eye (HP:0011885) | 3.34644038 |
| 29 | Atonic seizures (HP:0010819) | 3.34299232 |
| 30 | Hyperventilation (HP:0002883) | 3.33531199 |
| 31 | EEG with generalized epileptiform discharges (HP:0011198) | 3.27056655 |
| 32 | Abnormality of carpal bone ossification (HP:0006257) | 3.26169279 |
| 33 | Epidermoid cyst (HP:0200040) | 3.25142884 |
| 34 | Menorrhagia (HP:0000132) | 3.23215494 |
| 35 | Hypolipoproteinemia (HP:0010981) | 3.21832727 |
| 36 | Xanthomatosis (HP:0000991) | 3.21597493 |
| 37 | Broad palm (HP:0001169) | 3.20837938 |
| 38 | Abnormality of complement system (HP:0005339) | 3.20150036 |
| 39 | Epileptiform EEG discharges (HP:0011182) | 3.20139134 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 3.11938957 |
| 41 | Broad-based gait (HP:0002136) | 3.08855147 |
| 42 | Truncal ataxia (HP:0002078) | 3.07954128 |
| 43 | Excessive salivation (HP:0003781) | 3.07421931 |
| 44 | Drooling (HP:0002307) | 3.07421931 |
| 45 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.06446294 |
| 46 | Abnormality of the lower motor neuron (HP:0002366) | 3.05714677 |
| 47 | Impaired social interactions (HP:0000735) | 3.00512274 |
| 48 | Abnormal social behavior (HP:0012433) | 3.00512274 |
| 49 | Insidious onset (HP:0003587) | 2.99628461 |
| 50 | Termporal pattern (HP:0011008) | 2.99628461 |
| 51 | Hypophosphatemic rickets (HP:0004912) | 2.93471895 |
| 52 | Poor eye contact (HP:0000817) | 2.93285773 |
| 53 | Ankle clonus (HP:0011448) | 2.92595979 |
| 54 | Epiphyseal dysplasia (HP:0002656) | 2.90541699 |
| 55 | Alacrima (HP:0000522) | 2.89296668 |
| 56 | Depression (HP:0000716) | 2.88858509 |
| 57 | Abnormal tarsal ossification (HP:0008369) | 2.87985953 |
| 58 | Dysmetric saccades (HP:0000641) | 2.87924247 |
| 59 | Neurofibrillary tangles (HP:0002185) | 2.87466433 |
| 60 | Abnormality of macular pigmentation (HP:0008002) | 2.87212577 |
| 61 | Scanning speech (HP:0002168) | 2.82623913 |
| 62 | Genetic anticipation (HP:0003743) | 2.79913891 |
| 63 | Amyotrophic lateral sclerosis (HP:0007354) | 2.79281047 |
| 64 | Hemiparesis (HP:0001269) | 2.74833268 |
| 65 | Abnormality of the corticospinal tract (HP:0002492) | 2.74758378 |
| 66 | Intention tremor (HP:0002080) | 2.71902674 |
| 67 | Flat acetabular roof (HP:0003180) | 2.71137371 |
| 68 | Hypsarrhythmia (HP:0002521) | 2.69902942 |
| 69 | Asymmetry of the thorax (HP:0001555) | 2.66967204 |
| 70 | Status epilepticus (HP:0002133) | 2.66139798 |
| 71 | Dysmetria (HP:0001310) | 2.65561321 |
| 72 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.63470961 |
| 73 | Cerebral inclusion bodies (HP:0100314) | 2.61525190 |
| 74 | Abnormality of the lumbar spine (HP:0100712) | 2.60414722 |
| 75 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.59922791 |
| 76 | Torticollis (HP:0000473) | 2.58003294 |
| 77 | Hemiplegia (HP:0002301) | 2.55867253 |
| 78 | Postural instability (HP:0002172) | 2.50486780 |
| 79 | Abnormal hand bone ossification (HP:0010660) | 2.50290658 |
| 80 | Progressive inability to walk (HP:0002505) | 2.50244380 |
| 81 | Papillary thyroid carcinoma (HP:0002895) | 2.48664191 |
| 82 | Abnormality of the nasal septum (HP:0000419) | 2.47327615 |
| 83 | Abnormal ossification of hand bones (HP:0005921) | 2.45594163 |
| 84 | Abnormality of the wing of the ilium (HP:0011867) | 2.45450721 |
| 85 | Anxiety (HP:0000739) | 2.44886146 |
| 86 | Abnormality of binocular vision (HP:0011514) | 2.44683140 |
| 87 | Diplopia (HP:0000651) | 2.44683140 |
| 88 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.44535617 |
| 89 | Spastic gait (HP:0002064) | 2.43557266 |
| 90 | Arthropathy (HP:0003040) | 2.43521383 |
| 91 | Vitreoretinal degeneration (HP:0000655) | 2.43504870 |
| 92 | Osteomalacia (HP:0002749) | 2.42708948 |
| 93 | Decreased central vision (HP:0007663) | 2.40366766 |
| 94 | Vascular calcification (HP:0004934) | 2.40245295 |
| 95 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.40203593 |
| 96 | Impaired smooth pursuit (HP:0007772) | 2.39275209 |
| 97 | Diastasis recti (HP:0001540) | 2.38372672 |
| 98 | Irregular epiphyses (HP:0010582) | 2.37436897 |
| 99 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.36975137 |
| 100 | Impaired pain sensation (HP:0007328) | 2.35735564 |
| 101 | Abnormality of pain sensation (HP:0010832) | 2.35735564 |
| 102 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.34663012 |
| 103 | Abnormal eating behavior (HP:0100738) | 2.33436448 |
| 104 | Flared iliac wings (HP:0002869) | 2.31602760 |
| 105 | Tetraplegia (HP:0002445) | 2.29494837 |
| 106 | Polyphagia (HP:0002591) | 2.28255306 |
| 107 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.27790862 |
| 108 | Focal dystonia (HP:0004373) | 2.24247726 |
| 109 | Absent speech (HP:0001344) | 2.23897370 |
| 110 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.23405075 |
| 111 | Scotoma (HP:0000575) | 2.22081871 |
| 112 | Decreased lacrimation (HP:0000633) | 2.21416535 |
| 113 | Vaginal fistula (HP:0004320) | 2.21332546 |
| 114 | Facial shape deformation (HP:0011334) | 2.19184607 |
| 115 | Potter facies (HP:0002009) | 2.19184607 |
| 116 | Conjugated hyperbilirubinemia (HP:0002908) | 2.18837753 |
| 117 | Systemic lupus erythematosus (HP:0002725) | 2.17345915 |
| 118 | Cholecystitis (HP:0001082) | 2.17066469 |
| 119 | Abnormal gallbladder physiology (HP:0012438) | 2.17066469 |
| 120 | Limited elbow extension (HP:0001377) | 2.16577893 |
| 121 | Hypoalphalipoproteinemia (HP:0003233) | 2.13344297 |
| 122 | Gait imbalance (HP:0002141) | 2.12971105 |
| 123 | Agitation (HP:0000713) | 2.12164156 |
| 124 | Inability to walk (HP:0002540) | 2.11382916 |
| 125 | Urinary urgency (HP:0000012) | 2.10953768 |
| 126 | Supernumerary spleens (HP:0009799) | 2.10416914 |
| 127 | Craniofacial dystonia (HP:0012179) | 2.09437237 |
| 128 | Renal duplication (HP:0000075) | 2.09211929 |
| 129 | Clonus (HP:0002169) | 2.09154039 |
| 130 | Intrahepatic cholestasis (HP:0001406) | 2.09107792 |
| 131 | Increased serum pyruvate (HP:0003542) | 2.08516086 |
| 132 | Deep venous thrombosis (HP:0002625) | 2.08209546 |
| 133 | Skin nodule (HP:0200036) | 2.07026706 |
| 134 | Cardiovascular calcification (HP:0011915) | 2.06986990 |
| 135 | Akinesia (HP:0002304) | 2.06799536 |
| 136 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.06213128 |
| 137 | Absent epiphyses (HP:0010577) | 2.06213128 |
| 138 | Abnormality of glycolysis (HP:0004366) | 2.06095545 |
| 139 | Hepatoblastoma (HP:0002884) | 2.03313481 |
| 140 | Abnormality of the pubic bones (HP:0003172) | 2.02602861 |
| 141 | Enlarged kidneys (HP:0000105) | 2.01861275 |
| 142 | Gingival bleeding (HP:0000225) | 2.01600787 |
| 143 | Inappropriate behavior (HP:0000719) | 2.01085888 |
| 144 | Megalencephaly (HP:0001355) | 2.00154144 |
| 145 | Neuronal loss in central nervous system (HP:0002529) | 2.00109695 |
| 146 | Spastic tetraplegia (HP:0002510) | 1.99865192 |
| 147 | Bradykinesia (HP:0002067) | 1.99475902 |
| 148 | Abnormality of the intrinsic pathway (HP:0010989) | 1.99461864 |
| 149 | Mitral stenosis (HP:0001718) | 1.99296637 |
| 150 | Protrusio acetabuli (HP:0003179) | 1.97711132 |
| 151 | Generalized myoclonic seizures (HP:0002123) | 1.97626853 |
| 152 | Hypothermia (HP:0002045) | 1.97234951 |
| 153 | Aqueductal stenosis (HP:0002410) | 1.96714026 |
| 154 | Insomnia (HP:0100785) | 1.94787591 |
| 155 | Lower limb muscle weakness (HP:0007340) | 1.94204028 |
| 156 | Increased corneal curvature (HP:0100692) | 1.93925872 |
| 157 | Keratoconus (HP:0000563) | 1.93925872 |
| 158 | Gait ataxia (HP:0002066) | 1.93639637 |
| 159 | Heterotopia (HP:0002282) | 1.92977673 |
| 160 | Postural tremor (HP:0002174) | 1.92066259 |
| 161 | Poikilocytosis (HP:0004447) | 1.91688980 |
| 162 | Partial agenesis of the corpus callosum (HP:0001338) | 1.90247584 |
| 163 | Amblyopia (HP:0000646) | 1.89320921 |
| 164 | Hepatocellular carcinoma (HP:0001402) | 1.87179593 |
| 165 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87108357 |
| 166 | Severe visual impairment (HP:0001141) | 1.84737612 |
| 167 | Purpura (HP:0000979) | 1.84716663 |
| 168 | Stereotypic behavior (HP:0000733) | 1.84259207 |
| 169 | Exotropia (HP:0000577) | 1.83148946 |
| 170 | Abnormality of salivation (HP:0100755) | 1.81726592 |
| 171 | Arterial tortuosity (HP:0005116) | 1.80748386 |
| 172 | Cupped ribs (HP:0000887) | 1.80565958 |
| 173 | Widely spaced teeth (HP:0000687) | 1.79893862 |
| 174 | Midline defect of the nose (HP:0004122) | 1.78108287 |
| 175 | Abnormality of the acetabulum (HP:0003170) | 1.77353105 |
| 176 | Prolonged QT interval (HP:0001657) | 1.77245637 |
| 177 | Limb dystonia (HP:0002451) | 1.77080109 |
| 178 | Wide nose (HP:0000445) | 1.76409360 |
| 179 | Neonatal short-limb short stature (HP:0008921) | 1.74645673 |
| 180 | Blue irides (HP:0000635) | 1.74643486 |
| 181 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.74642940 |
| 182 | Abnormality of saccadic eye movements (HP:0000570) | 1.73088499 |
| 183 | Thrombophlebitis (HP:0004418) | 1.71048717 |
| 184 | Submucous cleft hard palate (HP:0000176) | 1.68460242 |
| 185 | Rickets (HP:0002748) | 1.66886612 |
| 186 | Abnormal foot bone ossification (HP:0010675) | 1.66002226 |
| 187 | Fat malabsorption (HP:0002630) | 1.65586125 |
| 188 | Abnormality of the lacrimal duct (HP:0011481) | 1.64518539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 5.79853983 |
| 2 | FGFR4 | 4.46466641 |
| 3 | FGFR3 | 3.81754008 |
| 4 | MAP3K4 | 3.50920375 |
| 5 | MAP3K9 | 3.10991596 |
| 6 | WNK4 | 2.99084316 |
| 7 | NTRK3 | 2.98490512 |
| 8 | PAK6 | 2.66687493 |
| 9 | MINK1 | 2.64843821 |
| 10 | MAP2K7 | 2.64627952 |
| 11 | PDGFRA | 2.56295348 |
| 12 | PKN2 | 2.50112941 |
| 13 | EPHA4 | 2.46023951 |
| 14 | CDK12 | 2.28001488 |
| 15 | AKT3 | 2.26325588 |
| 16 | NTRK2 | 2.19735484 |
| 17 | PIK3CA | 2.02890710 |
| 18 | DAPK2 | 2.02194091 |
| 19 | PHKG1 | 2.01818164 |
| 20 | PHKG2 | 2.01818164 |
| 21 | PBK | 2.00771985 |
| 22 | MAP2K4 | 1.99942305 |
| 23 | FGFR1 | 1.92884816 |
| 24 | CASK | 1.87524164 |
| 25 | CAMKK1 | 1.76624214 |
| 26 | BCR | 1.76201958 |
| 27 | RIPK1 | 1.65921251 |
| 28 | PRPF4B | 1.60667896 |
| 29 | MAPK13 | 1.60425365 |
| 30 | LATS1 | 1.58525709 |
| 31 | SIK2 | 1.53085773 |
| 32 | KSR1 | 1.43095591 |
| 33 | DYRK1B | 1.42567600 |
| 34 | STK38 | 1.38867253 |
| 35 | CDK5 | 1.38614611 |
| 36 | TNIK | 1.36962403 |
| 37 | NTRK1 | 1.36359299 |
| 38 | DDR2 | 1.29739074 |
| 39 | KSR2 | 1.28657481 |
| 40 | PRKD3 | 1.26520391 |
| 41 | DYRK1A | 1.24414661 |
| 42 | PKN1 | 1.21319542 |
| 43 | NEK1 | 1.15922170 |
| 44 | CAMKK2 | 1.12079116 |
| 45 | PRKCG | 1.11857597 |
| 46 | FES | 1.11155015 |
| 47 | SGK494 | 1.10395611 |
| 48 | SGK223 | 1.10395611 |
| 49 | MAP3K6 | 1.07490776 |
| 50 | CAMK1G | 1.07280128 |
| 51 | OBSCN | 1.05501900 |
| 52 | EEF2K | 1.01420229 |
| 53 | MARK2 | 1.01161834 |
| 54 | ERBB3 | 0.98869412 |
| 55 | RET | 0.94785775 |
| 56 | SGK2 | 0.94624361 |
| 57 | DYRK2 | 0.92929708 |
| 58 | FLT3 | 0.92470562 |
| 59 | PLK2 | 0.91006459 |
| 60 | LATS2 | 0.89921158 |
| 61 | CSNK1G2 | 0.89565188 |
| 62 | PINK1 | 0.87608741 |
| 63 | CDK15 | 0.86893272 |
| 64 | CDK14 | 0.86523158 |
| 65 | STK11 | 0.86152323 |
| 66 | SCYL2 | 0.84729261 |
| 67 | PRKCZ | 0.84593923 |
| 68 | CDK18 | 0.84417430 |
| 69 | PNCK | 0.82357210 |
| 70 | PRKAA1 | 0.81048202 |
| 71 | PAK3 | 0.78564408 |
| 72 | ERBB4 | 0.77850262 |
| 73 | INSRR | 0.77708786 |
| 74 | GRK5 | 0.77259661 |
| 75 | CAMK2A | 0.76240386 |
| 76 | TAOK2 | 0.76167863 |
| 77 | DAPK1 | 0.75983810 |
| 78 | BRD4 | 0.75121746 |
| 79 | CSNK1E | 0.73853332 |
| 80 | SGK3 | 0.73522533 |
| 81 | CDK11A | 0.72278732 |
| 82 | UHMK1 | 0.71990268 |
| 83 | PRKCH | 0.71615022 |
| 84 | CAMK1 | 0.70548579 |
| 85 | TGFBR2 | 0.68822635 |
| 86 | MAP3K13 | 0.68650046 |
| 87 | PRKAA2 | 0.68364309 |
| 88 | RPS6KB1 | 0.67995871 |
| 89 | STK39 | 0.67212823 |
| 90 | MAP3K7 | 0.67196442 |
| 91 | PDK1 | 0.66856620 |
| 92 | TRIB3 | 0.66436116 |
| 93 | PDPK1 | 0.66215312 |
| 94 | NEK2 | 0.64701816 |
| 95 | TAOK1 | 0.64277353 |
| 96 | PRKCE | 0.63049516 |
| 97 | PDGFRB | 0.62398932 |
| 98 | SGK1 | 0.61924445 |
| 99 | EPHA3 | 0.60995330 |
| 100 | TYRO3 | 0.60885679 |
| 101 | ERBB2 | 0.60779745 |
| 102 | MAPK12 | 0.58907328 |
| 103 | BRSK1 | 0.56696161 |
| 104 | RPS6KA3 | 0.55958063 |
| 105 | CAMK1D | 0.55077460 |
| 106 | CAMK2D | 0.53940569 |
| 107 | FGR | 0.53667260 |
| 108 | ALK | 0.52188538 |
| 109 | FGFR2 | 0.51671078 |
| 110 | FYN | 0.51126614 |
| 111 | FER | 0.50131925 |
| 112 | CDK3 | 0.49018025 |
| 113 | CDC42BPA | 0.47344891 |
| 114 | PRKG1 | 0.45750879 |
| 115 | RPS6KA2 | 0.45521064 |
| 116 | CSNK1D | 0.45520452 |
| 117 | CAMK4 | 0.44960019 |
| 118 | MAP3K2 | 0.44906273 |
| 119 | PRKCB | 0.44558146 |
| 120 | WNK1 | 0.42406987 |
| 121 | CSNK1A1L | 0.42288146 |
| 122 | ICK | 0.39914971 |
| 123 | MTOR | 0.39710074 |
| 124 | MAPK11 | 0.39322149 |
| 125 | MAPK10 | 0.39252583 |
| 126 | SRC | 0.39019280 |
| 127 | CAMK2B | 0.38739084 |
| 128 | MAPK9 | 0.37786415 |
| 129 | ROCK2 | 0.37528039 |
| 130 | CSNK1G3 | 0.37512284 |
| 131 | MAPK8 | 0.37127772 |
| 132 | IRAK2 | 0.34387252 |
| 133 | WNK3 | 0.34233127 |
| 134 | PTK2 | 0.33181646 |
| 135 | PRKACG | 0.33104089 |
| 136 | GSK3B | 0.30435025 |
| 137 | STK38L | 0.27513033 |
| 138 | MAP3K5 | 0.26972809 |
| 139 | CDK1 | 0.24422127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.80614552 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 3.23600197 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.22558580 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.81037370 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.70458873 |
| 6 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.55122408 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.48883226 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.48381021 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.48100112 |
| 10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.33516820 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.10248205 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 1.90773230 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 1.83578617 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.83089673 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.82107319 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.81761711 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.80351847 |
| 18 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.80123792 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.77749803 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.75800886 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.73571987 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.63694045 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.57924617 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.56847410 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.56028374 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.55067160 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.54905455 |
| 28 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.53064426 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.51841825 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.51492895 |
| 31 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.47951666 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43467119 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43324506 |
| 34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.39873981 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.38989598 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.38798936 |
| 37 | Long-term depression_Homo sapiens_hsa04730 | 1.33773196 |
| 38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.31916812 |
| 39 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.30175951 |
| 40 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.29116045 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.28012872 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.27450880 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26880327 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25383652 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22746634 |
| 46 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.22621879 |
| 47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.20147748 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 1.20079366 |
| 49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19259604 |
| 50 | Cocaine addiction_Homo sapiens_hsa05030 | 1.18637254 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.17240007 |
| 52 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.13880062 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13084961 |
| 54 | Axon guidance_Homo sapiens_hsa04360 | 1.12485121 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 1.09584191 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05556170 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.97691775 |
| 58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.96025043 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.95653388 |
| 60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.94332158 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93898747 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91763529 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.87072156 |
| 64 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.86992833 |
| 65 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.84946719 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.84877532 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.81172339 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80648575 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80029507 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78973423 |
| 71 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78146415 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77965654 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77624090 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.76859254 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.76853346 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75919955 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75403982 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.73278790 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72643772 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72531516 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71113499 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69012224 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69001954 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.66862070 |
| 85 | Alcoholism_Homo sapiens_hsa05034 | 0.66682719 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65910432 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65613709 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65003723 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63272305 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62192280 |
| 91 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62140455 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61871237 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59919025 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59588822 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59551807 |
| 96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.59229767 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59036116 |
| 98 | Adherens junction_Homo sapiens_hsa04520 | 0.58983506 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58221546 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57981883 |
| 101 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57930842 |
| 102 | * ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57930823 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57612953 |
| 104 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.56744732 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56441680 |
| 106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55071132 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.53103720 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51402912 |
| 109 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.50833079 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50261950 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49858414 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49379687 |
| 113 | Peroxisome_Homo sapiens_hsa04146 | 0.48529693 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47498195 |
| 115 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.47159918 |
| 116 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47007029 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46174025 |
| 118 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.45813508 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44267186 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43920888 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42479634 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.40897780 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40700228 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40350239 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.38745515 |
| 126 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38202934 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38038060 |
| 128 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37680334 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37161396 |
| 130 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.36926216 |
| 131 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34419907 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34272239 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33687011 |
| 134 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33596058 |
| 135 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33200373 |
| 136 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33079896 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.31344646 |
| 138 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31141689 |
| 139 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30765042 |
| 140 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30692220 |
| 141 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29128805 |
| 142 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28659787 |
| 143 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.27965884 |
| 144 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.26573865 |
| 145 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26524633 |

